This functional difference aligned with their clinical divergence: Case 2 had earlier onset, more severe cardiomyopathy, multisystem involvement, and fatal outcome without transplantation, while Case 1 survived post-heart transplantation with milder symptoms – reflecting the impact of partial versus complete LAMP2 deficit. This evidence concerns the gene LAMP2 and cardiomyopathy.